In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Cerep and Bristol-Myers Squibb sign collaboration agreement
BRISTOL-MYERS SQUIBB TO ACQUIRE ADNEXUS THERAPEUTICS
Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 Per Share in Cash
Bristol-Myers Squibb Announces Completion of ConvaTec Divestiture
InnaPhase and Bristol-Myers Squibb sign technology agreement
MorphoSys AG Announces Expanded Agreement With Bristol-Myers Squibb on Use of HuCAL GOLD®
Pharmagene and Bristol-Myers Squibb access agreement
CODEXIS, BRISTOL-MYERS SQUIBB SIGN RESEARCH AGREEMENT
Bristol-Myers Squibb to Acquire Medarex
Nerviano Medical Sciences announces agreement with Bristol-Myers Squibb to deliver oncology ECNs